Skip to Content
MilliporeSigma
  • Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.

Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.

mAbs (2014-12-09)
Julie A Douthwaite, Sudharsan Sridharan, Catherine Huntington, Jayne Hammersley, Rose Marwood, Jonna K Hakulinen, Margareta Ek, Tove Sjögren, David Rider, Cyril Privezentzev, Jonathan C Seaman, Peter Cariuk, Vikki Knights, Joyce Young, Trevor Wilkinson, Matthew Sleeman, Donna K Finch, David C Lowe, Tristan J Vaughan
ABSTRACT

Therapeutic monoclonal antibodies targeting G-protein-coupled receptors (GPCRs) are desirable for intervention in a wide range of disease processes. The discovery of such antibodies is challenging due to a lack of stability of many GPCRs as purified proteins. We describe here the generation of Fpro0165, a human anti-formyl peptide receptor 1 (FPR1) antibody generated by variable domain engineering of an antibody derived by immunization of transgenic mice expressing human variable region genes. Antibody isolation and subsequent engineering of affinity, potency and species cross-reactivity using phage display were achieved using FPR1 expressed on HEK cells for immunization and selection, along with calcium release cellular assays for antibody screening. Fpro0165 shows full neutralization of formyl peptide-mediated activation of primary human neutrophils. A crystal structure of the Fpro0165 Fab shows a long, protruding VH CDR3 of 24 amino acids and in silico docking with a homology model of FPR1 suggests that this long VH CDR3 is critical to the predicted binding mode of the antibody. Antibody mutation studies identify the apex of the long VH CDR3 as key to mediating the species cross-reactivity profile of the antibody. This study illustrates an approach for antibody discovery and affinity engineering to typically intractable membrane proteins such as GPCRs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Mouse IgG (γ-chain specific)−Biotin antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Freund′s Adjuvant, Complete, cell suspension
Sigma-Aldrich
Freund′s Adjuvant, Incomplete, liquid
Sigma-Aldrich
Anti-Human IgG (γ-chain specific), F(ab′)2 fragment−R-Phycoerythrin antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Vinyl laurate, ≥99.0% (GC)
Sigma-Aldrich
Vinyl laurate, produced by Wacker Chemie AG, Burghausen, Germany, ≥98% (GC)
Sigma-Aldrich
Calcium, SAJ first grade, ≥99.5%
Sigma-Aldrich
Calcium, dendritic pieces, purified by distillation, 99.9% trace metals basis
Sigma-Aldrich
Calcium, turnings, 99% trace metals basis
Sigma-Aldrich
Calcium, dendritic pieces, purified by distillation, 99.99% trace metals basis
Sigma-Aldrich
Calcium, granular, 99%
Sigma-Aldrich
Calcium, pieces, <1 cm, 99%
Sigma-Aldrich
Anti-Mouse IgM (μ-chain specific)–Biotin antibody produced in goat, affinity isolated antibody, buffered aqueous solution